Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN HYDROBROMIDE vs ELRANATAMAB-BCMM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN HYDROBROMIDE vs ELRANATAMAB-BCMM: Safety Overview

Metric ELETRIPTAN HYDROBROMIDE ELRANATAMAB-BCMM
Total FAERS Reports 2,158 570
Deaths Reported 12 120
Death Rate 0.6% 21.1%
Hospitalizations 271 168
Average Patient Age 52.6 yrs 69.5 yrs
% Female Patients 86.2% 49.4%
FDA Approval Date Aug 11, 2017 N/A
Manufacturer Zydus Pharmaceuticals USA Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A